ATR and breast cancer: In HR-proficient background, inactivation of POLQ increased cell death in ATR-deficient cells and sensitized breast cancer cells overexpressing POLQ to DNA damaging agents that cause replication stress (camptothecin and etoposide) or fork collapse (ATR inhibitors) [214].